Back
Raymond James Financial Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
74
RJF
Raymond James Financial
Last Price:
158.70
Seasonality Move:
10.11%
Buy
51
APLS
Apellis Pharmaceuticals
Last Price:
29.96
Seasonality Move:
22.1%
Buy
74
Raymond James Financial (RJF)
is a Buy
Is Raymond James Financial a Buy, Sell or Hold?
- The current Raymond James Financial [RJF] share price is $158.73. The Score for RJF is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- RJF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $30.02. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RJF Stock Price Chart
What is Raymond James Financial's stock price today?
-
The Raymond James Financial share price today is $158.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RJF is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $30.02
The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RJF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.53 | Buy |
| Relative Strength Index (14 RSI): | 72.97 | Buy |
| Chaikin Money Flow: | 555696 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (129.97 - 150.85) | Buy |
| Bollinger Bands (100): | (111.35 - 135.17) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 58.06 | Buy |
| Chaikin Money Flow: | 2150169 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.93 - 28.43) | Buy |
| Bollinger Bands (100): | (29.7 - 39.56) | Sell |
RJF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 151.16 | Buy |
| 20-day SMA: | 143.89 | Buy |
| 50-day SMA: | 130.52 | Buy |
| 200-day SMA: | 122.32 | Buy |
| 8-day EMA: | 152.32 | Buy |
| 20-day EMA: | 144.86 | Buy |
| 50-day EMA: | 134.45 | Buy |
| 200-day EMA: | 122.11 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.4 | Buy |
| 20-day SMA: | 27.8 | Buy |
| 50-day SMA: | 31.23 | Sell |
| 200-day SMA: | 44.21 | Sell |
| 8-day EMA: | 28.61 | Buy |
| 20-day EMA: | 28.43 | Buy |
| 50-day EMA: | 30.68 | Sell |
| 200-day EMA: | 40.64 | Sell |
Raymond James Financial Earnings Growth & RJF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.07 per share, and an increase next year of $0.89 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Raymond James Financial Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||